| Name | Market Cap | Current Price | P/E Ratio | Revenue Growth 1Y | Net Margin | ROE | FCF Yield | Debt/Equity |
|---|---|---|---|---|---|---|---|---|
| STCStewart Information Services Corporation | 2.01B | 66.64 | 25.53 | 10.33% | 3.29% | 6.07% | 4.73% | 0.40 |
| BOWBowhead Specialty Holdings Inc. | 831.05M | 25.35 | 19.65 | 50.16% | 10.12% | 12.21% | 35.04% | |
| AXSAXIS Capital Holdings Limited | 7.73B | 100.34 | 8.12 | 7.66% | 16.11% | 15.91% | 23.87% | 0.24 |
| Dec 2022 | Dec 2023 | Dec 2024 | |
|---|---|---|---|
| Revenue | 187.6M | 283.42M | 425.59M |
| Revenue Growth % | - | 0.51% | 0.5% |
| Medical Costs & Claims | 126.95M | 187.22M | 280.5M |
| Medical Cost Ratio % | - | - | - |
| Gross Profit | 60.65M | 96.2M | 145.1M |
| Gross Margin % | - | - | - |
| Gross Profit Growth % | - | 0.59% | 0.51% |
| Operating Expenses | 45.99M | 64.09M | 94.56M |
| OpEx / Revenue % | - | - | - |
| Depreciation & Amortization | 727K | 2.27M | 3.87M |
| Combined Ratio % | - | - | - |
| Operating Income | 14.66M | 32.12M | 50.53M |
| Operating Margin % | - | - | - |
| Operating Income Growth % | - | 1.19% | 0.57% |
| EBITDA | 15.39M | 34.38M | 54.4M |
| EBITDA Margin % | - | - | - |
| Interest Expense | 0 | 0 | 725K |
| Non-Operating Income | 0 | 0 | -725K |
| Pretax Income | 14.66M | 32.12M | 50.53M |
| Pretax Margin % | - | - | - |
| Income Tax | 3.4M | 7.07M | 12.29M |
| Effective Tax Rate % | - | - | - |
| Net Income | 11.26M | 25.05M | 38.24M |
| Net Margin % | - | - | - |
| Net Income Growth % | - | 1.23% | 0.53% |
| EPS (Diluted) | 0.36 | 0.79 | 1.29 |
| EPS Growth % | - | 1.19% | 0.63% |
| EPS (Basic) | 0.36 | 0.79 | 1.31 |
| Diluted Shares Outstanding | 31.53M | 31.53M | 29.68M |
| Dec 2022 | Dec 2023 | Dec 2024 | |
|---|---|---|---|
| Total Assets | 565.21M | 1.03B | 1.65B |
| Asset Growth % | - | 0.82% | 0.61% |
| Total Investment Assets | 282.92M | 0 | 889.99M |
| Long-Term Investments | 282.92M | 0 | 889.99M |
| Short-Term Investments | 282.92M | 0 | 889.99M |
| Total Current Assets | 0 | 118.07M | 0 |
| Cash & Equivalents | 64.66M | 118.07M | 97.48M |
| Receivables | 1000K | 1000K | 1000K |
| Other Current Assets | -515.14M | -39.92M | -1.46B |
| Goodwill & Intangibles | 0 | -269.03M | 0 |
| Goodwill | 0 | -288.44M | 0 |
| Intangible Assets | 0 | 19.41M | 0 |
| PP&E (Net) | 6.05M | 7.6M | 6.84M |
| Other Assets | -288.97M | 610.34M | -896.83M |
| Total Liabilities | 481.83M | 835.78M | 1.28B |
| Total Debt | 0 | 0 | 0 |
| Net Debt | -64.66M | -118.07M | -97.48M |
| Long-Term Debt | 0 | 0 | 0 |
| Short-Term Debt | 0 | 0 | 0 |
| Total Current Liabilities | 0 | 0 | 0 |
| Accounts Payable | 23.69M | 40.44M | 51.86M |
| Deferred Revenue | 0 | 0 | 0 |
| Other Current Liabilities | -37.23M | -55.38M | -71.44M |
| Deferred Taxes | 0 | 0 | 0 |
| Other Liabilities | 0 | 835.78M | 0 |
| Total Equity | 83.37M | 192.08M | 370.44M |
| Equity Growth % | - | 1.3% | 0.93% |
| Shareholders Equity | 83.37M | 192.08M | 370.44M |
| Minority Interest | 0 | 0 | 0 |
| Retained Earnings | -381K | 24.67M | 62.91M |
| Common Stock | 0 | 240K | 327K |
| Accumulated OCI | -16.69M | -11.37M | -11.15M |
| Return on Equity (ROE) | 0.14% | 0.18% | 0.14% |
| Return on Assets (ROA) | 0.02% | 0.03% | 0.03% |
| Equity / Assets | - | - | - |
| Debt / Equity | - | - | - |
| Book Value per Share | 2.64 | 6.09 | 12.48 |
| Tangible BV per Share | - | - | - |
| Dec 2022 | Dec 2023 | Dec 2024 | |
|---|---|---|---|
| Cash from Operations | 181.64M | 236.22M | 294.29M |
| Operating CF Growth % | - | 0.3% | 0.25% |
| Operating CF / Revenue % | - | - | - |
| Net Income | 11.26M | 25.05M | 38.24M |
| Depreciation & Amortization | 727K | 2.27M | 3.87M |
| Stock-Based Compensation | 368K | 683K | 4.1M |
| Deferred Taxes | -2.97M | -4.36M | -6.17M |
| Other Non-Cash Items | 570K | -2.27M | -532K |
| Working Capital Changes | 171.69M | 214.86M | 254.77M |
| Cash from Investing | -187.46M | -274.76M | -325.88M |
| Capital Expenditures | -3.97M | -3.82M | -3.11M |
| Acquisitions | 0 | 0 | 0 |
| Purchase of Investments | -198.29M | -367.25M | -612.93M |
| Sale/Maturity of Investments | 1000K | 1000K | 1000K |
| Other Investing | 0 | 0 | 0 |
| Cash from Financing | -1M | 77.66M | 133.89M |
| Dividends Paid | -25M | 0 | 0 |
| Share Repurchases | -25M | 0 | 0 |
| Stock Issued | 24M | 77.66M | 133.82M |
| Debt Issuance (Net) | -1000K | 1000K | 0 |
| Other Financing | 26M | -77.66M | 64K |
| Net Change in Cash | -6.81M | 39.12M | 102.29M |
| Exchange Rate Effect | 0 | 1K | 0 |
| Cash at Beginning | 87.47M | 80.65M | 119.77M |
| Cash at End | 80.65M | 119.77M | 222.06M |
| Free Cash Flow | 177.67M | 232.41M | 291.18M |
| FCF Growth % | - | 0.31% | 0.25% |
| FCF Margin % | - | - | - |
| FCF per Share | 5.64 | 7.37 | 9.81 |
| Metric | 2022 | 2023 | 2024 |
|---|---|---|---|
| Combined Ratio | 92.19% | 88.67% | 88.13% |
| Medical Cost Ratio | 67.67% | 66.06% | 65.91% |
| Return on Equity (ROE) | 13.5% | 18.19% | 13.6% |
| Return on Assets (ROA) | 1.99% | 3.14% | 2.85% |
| Equity / Assets | 14.75% | 18.69% | 22.39% |
| Book Value / Share | 2.64 | 6.09 | 12.48 |
| Revenue Growth | - | 51.07% | 50.16% |
Bowhead Specialty Holdings Inc. (BOW) has a price-to-earnings (P/E) ratio of 19.7x. This is roughly in line with market averages.
Bowhead Specialty Holdings Inc. (BOW) grew revenue by 50.2% over the past year. This is strong growth.
Yes, Bowhead Specialty Holdings Inc. (BOW) is profitable, generating $52.5M in net income for fiscal year 2024 (9.0% net margin).
Bowhead Specialty Holdings Inc. (BOW) has a return on equity (ROE) of 13.6%. This is reasonable for most industries.
Bowhead Specialty Holdings Inc. (BOW) has a combined ratio of 88.1%. A ratio below 100% indicates underwriting profitability.